Breast Lesion Localization Methods Market Report: Including Growth, Factors, Development, Trends By 2025

The Global Breast Lesion Localization Methods Market is accounted to reach USD 1367.61 million by 2025 from USD 544.56 million in 2017, at a CAGR of 12.3% in the forecast period 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as Technological advancements in breast localization, rising prevalence of breast cancer and increasing breast cancer surgeries, increasing number of government and non-government reimbursement policies, increasing awareness among people for the diagnosis of breast cancer and innovations of new technologies and methods for breast cancer lesion localization.

 Free access to the sample page of the report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-lesion-localization-methods-market

The key market players for Global breast lesion localization methods market are listed below:

  • R. Bard, Inc.
  • CP Medical, Inc.
  • Cianna Medical
  • Cook Group
  • STERYLAB S.r.l.
  • SOMATEX Medical Technologies GmbH
  • Elucent Medical
  • ARGON MEDICAL
  • Tsunami S.r.l.
  • D.L. srl
  • Biomedical Srl

The market is segmented into:

  • Type
  • Biopsy techniques
  • end-user
  • Geography

For Any Query speak to our Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-breast-lesion-localization-methods-market

The global Breast Lesion Localization Methods Market is segmented on the basis of product type, end-user and geography. The report provides data for 2015 to 2024, 2016 being the current year while 2017 to 2024 is the forecast period for the report.

The global breast lesion localization market is segmented based on type into wire localization, radioisotope localization, magnetic tracers and others. Global breast lesion localization market is dominated by wire localization with 37.3% market share in 2017, growing at a CAGR of 12.0% in the forecast period. The radioisotope localization is further sub segmented into radioactive seed localization and radio occult lesion localization.

The global breast lesion localization market is segmented on the basis of biopsy techniques into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others. Global breast lesion localization market is dominated by fine needle aspiration biopsy with 32.3% market share in 2017, growing at a CAGR of 12.5% in the forecast period. The surgical biopsy is further sub segmented into incisional biopsy and excisional biopsy.

The global Breast Lesion Localization Market is segmented on the basis of end user into diagnostic centers, hospitals, oncology clinics and ambulatory surgical centers. Global breast lesion localization market is dominated by hospitals with 35.8% market share in 2017, growing at a CAGR of 12.8% in the forecast period.

Based on geography, the Global breast lesion localization methods market is segmented into geographical regions, such as,

  • North- America,
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Covered in this report

The report covers the present scenario and the growth prospects of the Global breast lesion localization methods for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

To Access Full Report @ http://databridgemarketresearch.com/reports/global-breast-lesion-localization-methods-market/

TABLE OF CONTENTS GLOBAL BREAST LESION LOCALIZATION METHODS MARKET

  1. INTRODUCTION

1.1 OVERVIEW OF THE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET
1.2 CURRENCY AND PRICING
1.3 LIMITATION
1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET

2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY MODELLING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS 

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING PREVALENCE OF BREAST CANCER
3.1.2 INCREASING NUMBER OF GOVERNMENT AND NON-GOVERNMENT REIMBURSEMENT POLICIES
3.1.3 INCREASING AWARENESS AMONG PEOPLE TO DIAGNOSIS OF BREAST CANCER

3.2 RESTRAINTS

3.2.1 PRODUCT APPROVAL AND PRODUCT RECALL BY FDA

3.3 OPPORTUNITIES

3.3.1 INNOVATIONS OF NEW TECHNOLOGIES AND METHODS FOR BREAST CANCER LESION LOCALIZATION

3.4 CHALLENGES

3.4.1 RISK ASSOCIATED WITH THE BREAST SURGERY AND PAINFUL CONSEQUENCES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE

6.1 OVERVIEW
6.2 WIRE LOCALIZATION
6.3 RADIOISOTOPE LOCALIZATION
6.3.1 RADIOACTIVE SEED LOCALIZATION
6.3.2 RADIO OCCULT LESION LOCALIZATION
6.4 MAGNETIC TRACERS
6.5 OTHERS

7 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY BIOPSY TECHNIQUES

7.1 OVERVIEW
7.2 FINE NEEDLE ASPIRATION BIOPSY
7.3 CORE NEEDLE BIOPSY
7.4 SURGICAL BIOPSY
7.4.1 INCISIONAL BIOPSY
7.4.2 EXCISIONAL BIOPSY
7.5 VACUUM-ASSISTED BREAST BIOPSY
7.6 OTHERS

8 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY END USER

8.1 OVERVIEW
8.2 DIAGNOSTIC CENTERS
8.3 HOSPITALS
8.4 ONCOLOGY CLINICS
8.5 AMBULATORY SURGICAL CENTERS

9 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY

9.1 COUNTRY WISE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1 NORTH AMERICA

9.1.1.1 U.S.
9.1.1.2 CANADA
9.1.1.3 MEXICO

9.1.2 EUROPE

9.1.2.1. GERMANY
9.1.2.2 FRANCE
9.1.2.3 U.K.
9.1.2.4 ITALY
9.1.2.5 SPAIN
9.1.2.6 RUSSIA
9.1.2.7 TURKEY
9.1.2.8 BELGIUM
9.1.2.9 NETHERLANDS
9.1.2.10 SWITZERLAND
9.1.2.11 REST OF EUROPE

9.1.3 ASIA-PACIFIC (APAC)

9.1.3.1 JAPAN
9.1.3.2 CHINA
9.1.3.3 SOUTH KOREA
9.1.3.4 INDIA
9.1.3.5 AUSTRALIA
9.1.3.6 SINGAPORE
9.1.3.7 THAILAND
9.1.3.8 MALAYSIA
9.1.3.9 INDONESIA
9.1.3.10 PHILIPPINES
9.1.3.11 REST OF APAC

9.1.4 SOUTH AMERICA

9.1.4.1 BRAZIL
9.1.4.2 REST OF LATIN AMERICA

9.1.5 MIDDLE EAST AND AFRICA

9.1.5.1 SAUDI ARABIA
9.1.5.2 SOUTH AFRICA
9.1.5.3 REST OF MIDDLE EAST AND AFRICA

9.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: COMPETITIVE LANDSCAPE

10.1. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.4. ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11 BREAST LESION LOCALIZATION METHODS MARKET, COMPANY PROFILES

11.1 C. R. BARD, INC.

11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL ANALYSIS
11.1.3 PRODUCT MATRIX
11.1.4 RECENT DEVELOPMENTS
11.1.5 DATABRIDGE ANALYSIS

11.2 CP MEDICAL, INC.

10.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL ANALYSIS
11.2.3 PRODUCT MATRIX
11.2.4 RECENT DEVELOPMENTS
11.2.5 DATABRIDGE ANALYSIS

11.3 CIANNA MEDICAL

11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL ANALYSIS
11.3.3 PRODUCT MATRIX
11.3.4 RECENT DEVELOPMENTS
11.3.5 DATABRIDGE ANALYSIS

11.4 COOK

11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL ANALYSIS
11.4.3 PRODUCT MATRIX
11.4.4 RECENT DEVELOPMENTS
11.4.5 DATABRIDGE ANALYSIS

11.5 STERYLAB S.R.L.

11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL ANALYSIS
11.5.3 PRODUCT MATRIX
11.5.4 RECENT DEVELOPMENTS
11.5.5 DATABRIDGE ANALYSIS

11.6 SOMATEX

11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL ANALYSIS
11.6.3 PRODUCT MATRIX
11.6.4 RECENT DEVELOPMENTS
11.6.5 DATABRIDGE ANALYSIS

11.7 ELUCENT MEDICAL

11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL ANALYSIS
11.7.3 PRODUCT MATRIX
11.7.4 RECENT DEVELOPMENTS
11.7.5 DATABRIDGE ANALYSIS

11.8 ARGON MEDICAL

11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL ANALYSIS
11.8.3 PRODUCT MATRIX
11.8.4 RECENT DEVELOPMENTS
11.8.5 DATABRIDGE ANALYSIS

11.9 TSUNAMI MEDICAL SRL

11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL ANALYSIS
11.9.3 PRODUCT MATRIX
11.9.4 RECENT DEVELOPMENTS
11.9.5 DATABRIDGE ANALYSIS

11.10 MDL

11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL ANALYSIS
11.10.3 PRODUCT MATRIX
11.10.4 RECENT DEVELOPMENTS
11.10.5 DATABRIDGE ANALYSIS

11.11 BIOMEDICAL SRL

11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL ANALYSIS
11.11.3 PRODUCT MATRIX
11.11.4 RECENT DEVELOPMENTS
11.11.5 DATABRIDGE ANALYSIS

11.12 RI.MOS. SRL

11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL ANALYSIS
11.12.3 PRODUCT MATRIX
11.12.4 RECENT DEVELOPMENTS
11.12.5 DATABRIDGE ANALYSIS

11.13 LAURANEMEDICAL.COM

11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL ANALYSIS
11.13.3 PRODUCT MATRIX
11.13.4 RECENT DEVELOPMENTS
11.13.5 DATABRIDGE ANALYSIS

11.14 BIOPSYBELL SRL

11.14.1 COMPANY OVERVIEW
11.14.2 FINANCIAL ANALYSIS
11.14.3 PRODUCT MATRIX
11.14.4 RECENT DEVELOPMENTS
11.14.5 DATABRIDGE ANALYSIS

12 APPENDIX

13 ABOUT DATA BRIDGE MARKET RESEARCH

 

Related Report:

Europe Medical Device Packaging Market – Industry Trends and Forecast to 2024

Europe Medical Device Packaging Market, By Product Type (Manual, Powered),Type (Disposable, Reuse), Application (Abdominal, Pelvis, General Surgery, Cardiac, Thoracic, Orthopedic, Hemorrhoids, Cosmetic, Pediatric), End User (Hospital, ASC, Clinic), Distribution Channel (Retail, Direct Tenders), Country (Global Surgical Staplers Market, By Product Type (Manual, Powered),Type (Disposable, Reuse), Application (Abdominal, Pelvis, General Surgery, Cardiac, Thoracic, Orthopedic, Hemorrhoids, Cosmetic, Pediatric), End User (Hospital, ASC, Clinic), Distribution Channel (Retail, Direct Tenders),country (Germany, France, U.K., Switzerland, Netherlands, Spain, Russia, Turkey, Belgium and rest of Europe) – Industry Trends and Forecast to 2024)

Report Access@ http://databridgemarketresearch.com/reports/europe-medical-device-packaging-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.